Loading the map…
Private limited company registered in Belfast, classed under “Specialists medical practice activities”.
Headline figures
FY to May 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
What the numbers say
3 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2023* | 2024 | 2025 |
|---|---|---|---|
| Profit after tax | — | ||
| Turnover | |||
| Net assets | |||
| Cash | |||
| Employees |
Every figure for all 3 years
“—” means we did not find the figure in a source; it is never filled with an estimate. * Restated: the next year's accounts printed different figures for this year, and those later figures are shown.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2023 | 2024 | 2025 |
|---|---|---|---|
| Current assets | |||
| of which debtors | |||
| of which cash | |||
| Creditors due within a year | |||
| Net assets | |||
| Ratios | |||
| Current ratioCurrent assets for every £1 owed within a year | |||
| Cash ratioCash for every £1 owed within a year | |||
5 balance-sheet lines and 2 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Questions people ask
›What does Otofetal do?
Private limited company registered in Belfast, classed under “Specialists medical practice activities”.
›How much turnover does Otofetal make?
Answered in the full report
›Is Otofetal profitable?
Otofetal's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Otofetal?
Answered in the full report
›Where is Otofetal based?
Its registered office is 84 Balmoral Avenue, Belfast, BT9 6NY, in Belfast.
›When was Otofetal founded?
Otofetal Ltd was incorporated on 30 May 2022.
›Is Otofetal still trading?
The register lists Otofetal Ltd as active.